Wells Fargo & Company Vivos Therapeutics, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.18 - $0.52 $0 - $0	-1 Reduced 0.63%	157 $0
Q2 2023 Aug 15, 2023	BUY	$0.31 - $0.55 $9 - $16	30 Added 23.44%	158 $0
Q1 2023 May 12, 2023	BUY	$0.32 - $1.88 $3 - $22	12 Added 10.34%	128 $0
Q4 2022 Feb 13, 2023	BUY	$0.35 - $20.75 $1 - $62	3 Added 2.65%	116 $0
Q3 2022 Nov 14, 2022	SELL	$0.83 - $21.25 $5 - $148	-7 Reduced 5.83%	113 $0
Q2 2022 Aug 12, 2022	BUY	$1.12 - $2.18 $10 - $19	9 Added 8.11%	120 $0
Q1 2022 May 16, 2022	SELL	$1.63 - $3.63 $3,256 - $7,252	-1,998 Reduced 94.74%	111 $0
Q3 2021 Nov 15, 2021	BUY	$2.71 - $5.9 $5,571 - $12,130	2,056 Added 3879.25%	2,109 $8,000
Q2 2021 Aug 16, 2021	BUY	$4.83 - $9.67 $140 - $280	29 Added 120.83%	53 $0
Q1 2021 May 13, 2021	BUY	$6.01 - $8.9 $144 - $213	24 New	24 $0

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.